MedTrace Logo

Hand Rehabilitation Based on a RobHand Exoskeleton in Stroke Patients: a Case Series Study

NCT05598892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2022-10-28

No results posted yet for this study

Summary

The following study seeks to provide information regarding to the RobHand exoskeleton for hand neuromotor maintenance and/or rehabilitation, developed by the University of Valladolid, Spain.

Conditions

Interventions

DEVICE

Training with Robotic Hand Exoskeleton

The intervention consists in Robotic Hand training sessions. Each subject received 16 sessions lasting 60 minutes each and a frequency of 2 sessions per week. The sessions will be applied by an Ocupational Therapist with experience in Robotic training. Robhand exoskeleton (ITAP, Valladolid, Spain) is an exoskeleton-type electromechanical device, which is attached to the patient's hand and provides assistance for performing different types of finger movement rehabilitation therapies. The exoskeleton is composed of five independent subassemblies that are placed on a platform which is located on the back of the hand, with the exception of the thumb subassembly that is mounted on a separated module connected to the hand support platform through a linkage device.

Sponsors & Collaborators

  • University of Valladolid

    collaborator OTHER

  • Universidad de Magallanes

    collaborator OTHER

  • Corporación de Rehabilitación Club de Leones Cruz del Sur

    lead OTHER

Principal Investigators

  • Asterio H Andrade, PhD · Rehabilitation Center Club de Leones Cruz del Sur

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05598892 on ClinicalTrials.gov